<DOC>
	<DOCNO>NCT00638547</DOCNO>
	<brief_summary>This protocol examine whether enzyme alpha-L-iduronidase ( Laronidase ) , deliver spinal fluid patient Hurler syndrome interval bone marrow transplant , safe effective approach slow neurologic degeneration see Hurler patient undergo transplantation .</brief_summary>
	<brief_title>Intrathecal Enzyme Replacement Hurler Syndrome</brief_title>
	<detailed_description>Subjects receive infusion Laronidase his/her spinal fluid approximately 12 week , 2 week , 100 day 6 month transplant . This procedure do lumbar puncture ( also call `` spinal tap '' ) .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<mesh_term>Mucopolysaccharidosis I</mesh_term>
	<criteria>Patients diagnosis MPS IH ( Hurler syndrome ) candidate protocol consider hematopoietic stem cell transplantation accord University Minnesota guideline . Patients less 6 month old , old 3 year age . There history clinicallysevere hypersensitivity Laronidase . There contraindication repeat lumbar puncture . The family willing undergo necessary procedure evaluation inherent study . Consent sign participation 200409 study intravenous Laronidase administration .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hurler Syndrome</keyword>
	<keyword>mucopolysaccharidosis type I</keyword>
	<keyword>Iduronidase deficiency</keyword>
</DOC>